![Jing Jiang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jing Jiang
Direktor/Vorstandsmitglied bei Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd.
Ursprung des Netzwerks ersten Grades von Jing Jiang
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd.
![]() Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. Medical SpecialtiesHealth Technology Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. is a private company that manufactures medical equipment. The company is based in Wuxi, China. The Chinese company was founded in 1999. The CEO is Qing Song Sheng.
5
| Private Company | Medical Specialties | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jing Jiang
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Yale University | College/University | Doctorate Degree | |
JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD. | Containers/Packaging | Director/Board Member | |
Genfleet Therapeutics (Shanghai), Inc.
![]() Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Miscellaneous Commercial Services | Director/Board Member | |
GEMPHARMATECH CO., LTD. | Biotechnology | Director/Board Member | |
Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
![]() Innolake Pharmaceuticals (Hangzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Innolake Pharmaceuticals (Hangzhou) Co., Ltd. is a company based in Hangzhou, China that engages in the development and commercialization of therapeutic drugs for tumors and immune system diseases. The Chinese company was founded in 2020 by Ru Lei Chen and Ming De Xia, with Ming De Xia serving as the CEO since 2020. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
China | 5 |
Vereinigte Staaten | 2 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Process Industries | 2 |
Commercial Services | 2 |
Operativ
Director/Board Member | 8 |
Chief Executive Officer | 1 |
Chairman | 1 |
Doctorate Degree | 1 |
Independent Dir/Board Member | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Dan Liu | 6 |
Qing Song Sheng | 1 |
Qing Zhong Tan | 1 |
Zeng Jiao Sui | 1 |
Yun Feng | 1 |
- Börse
- Insiders
- Jing Jiang
- Unternehmensverbindungen